(Reuters)—Medications that suppress the immune system—necessary for many chronic diseases—do not worsen outcomes of COVID-19 cases, new data suggest. Researchers looked back at 2,121 adults hospitalized for COVID-19 between March and August, including 108 who were taking immunosuppressive drugs (primarily prednisone, tacrolimus or mycophenolate mofetil). After accounting for patients’ general baseline health status, researchers found…
U.S. Teaching Hospitals Are Expensive, But Have Lower Death Rates
(Reuters Health)—Academic medical centers, increasingly spurned by insurers for being more expensive than community hospitals, appear to have lower death rates for older adults than other facilities, a U.S. study suggests. Researchers reviewed millions of records for patients aged 65 and older and insured by Medicare, the U.S. health program for the elderly. They found…
Hospitals Have Lower Death Rates During Surprise Inspections
(Reuters Health)—Patients may be less likely to die in U.S. hospitals during weeks when accreditation inspectors show up unannounced than during other times of the year, a recent U.S. study suggests. Researchers examined mortality data for 1,984 hospitals nationwide from 2008 to 2012. During surprise inspections, 7.03% of patients died within 30 days of being…
Gout Treatment & Care Remain Suboptimal
A recent analysis compared the care of patients with RA with that received by patients with gout, finding that hospitalization and costs for patients with gout have increased, but both are decreasing for patients with RA. Unlike RA, significant advances in treatment have not been made for gout, despite its increasing prevalence, and patients may land in the hospital unnecessarily…
Rheumatologists’ Involvement Aids in Gout Diagnosis, Follow-up for Inpatients
Two studies find rheumatologists can help optimally manage gout episodes